Galectin 3 expression in regional lymph nodes and lymph node metastases of oral squamous cell carcinomas

BMC Cancer

Table 1 Galectin 3 (Gal3) cell count (cells/mm²) and Gal3/CD68 expression ratio in lymph node specimens of oscc patients

Gal3 expression in lymph nodes
Marker	n	Gal3 IFZ		Gal3 sinus		Ratio Gal3/CD68 IFZ		Ratio Gal3/CD68 sinus
Marker	n	Median	SD	Median	SD	Median	SD	Median	SD
T-Status
T1	9	69	46	175	172	0.18	0.16	0.16	0.07
T2	14	153	152	274	272	0.48	0.33	0.34	0.21
p-value		0.040		0.357		0.036		0.044
N-Status
N0	15	96	144	209	235	0.37	0.29	0.21	0.23
N+	8	142	116	271	263	0.50	0.31	0.32	0.16
p-value		0.649		0.480		0.231		0.881
L-Status
L0	17	118	110	227	217	0.43	0.27	0.23	0.21
L1	6	176	186	277	334	0.27	0.40	0.31	0.18
p-value		0.289		0.412		0.816		0.865
Pn-Status
Pn0	13	123	122	196	241	0.41	0.31	0.23	0.22
Pn1	7	51	179	263	304	0.21	0.38	0.23	0.17
p-value		0.553		0.498		0.960		0.942
Grading
G2	15	118	124	249	224	0.42	0.32	0.26	0.20
G3	6	117	174	212	348	0.25	0.26	0.16	0.21
p-value		0.848		0.929		0.659		0.622

Galectin 3 (Gal3) cell counts (positive cells/mm²) and the ratio of Galectin 3 and CD68 positive cells in cervical lymph nodes of oscc patients depending on histomorphologic parameters of the primary tumor (T-, N-, L-, Pn-Status, Grading). Results for the interfollicular zone (IFZ) and the sinuses of tumor-free lymph nodes are given. Values represent the median, standard deviation (SD) and p-value (ANOVA)
Significant p-values are indicated in bold letters

ISSN: 1471-2407